HOMOCYSTEINEMIA--A RISK FACTOR FOR OSTEOPOROSIS
HOMOCYSTEINEMIA--A RISK FACTOR FOR OSTEOPOROSIS
批准号:
2131706
负责人:
CHARLES W PRINCE
金额:
$2.14万
依托单位国家:
美国
项目类别:
财政年份:
1993
资助国家:
美国
项目状态:
已结题
起止时间:
1993-08-01 至 1995-07-31
关键词:
SDS polyacrylamide gel electrophoresis aminoacid metabolism biomarker blood chemistry bone marrow cell cycle disease /disorder prevention /control disease /disorder proneness /risk extracellular matrix growth media homeostasis homocysteine homocystinuria laboratory rat musculoskeletal disorder diagnosis normal ossification osteoclasts osteocytes osteogenesis osteoporosis pathologic bone resorption tissue /cell culture
中文摘要
骨质疏松症是一种慢性疾病,在
人口日益庞大,很难诊断和治疗。一个
重要的目标是预防骨质疏松症,尽管它是多因素的
病因学阻碍了对其所有原因的阐明。同型半胱氨酸尿症
由胱硫醚β缺乏所致的先天性代谢错误
合酶活性,其特征是同型半胱氨酸水平升高
血液和脊柱和长骨的严重骨质疏松起病早。
在没有遗传病的情况下,发生同型半胱氨酸血症的可能性,
随着年龄和绝经后的增加而增加,可能是由几个
因素:营养缺乏(维生素B6和叶酸)、吸收不良
(由于维生素B12缺乏、过量饮酒或非类固醇
使用抗炎药物),高蛋氨酸饮食(即高蛋氨酸动物
蛋白质饮食)和/或未知因素。因此,我们的假设是
同型半胱氨酸水平升高是另一个危险因素
骨质疏松。
我们将研究同型半胱氨酸升高对骨细胞的影响
生长、细胞外基质合成、骨形成和骨吸收
通过使用体外方法。大鼠骨髓细胞,在
适宜的培养条件,可诱导成骨或产生
活跃的破骨细胞。我们将添加外源性同型半胱氨酸或使
细胞产生高水平的同型半胱氨酸(通过施加营养
缺陷)和测定对上述参数的影响。因此,我们
应能够评估升高的同型半胱氨酸对两者的影响
骨的动态平衡、形成和吸收的成分
级别。
如果获得了支持我们假设的数据,我们将进行
老年高血压患者血浆同型半胱氨酸水平的横断面研究
没有骨质疏松症,并最终进行了一项干预试验
哪些饮食策略被用来降低同型半胱氨酸水平。
英文摘要
Osteoporosis, a chronic disease causing significant morbidity among an
increasingly large population, is difficult to diagnose and treat. An
important goal is prevention of osteoporosis, though its multi-factorial
etiology has prevented elucidation of all its causes. Homocystinuria, an
inborn error of metabolism resulting from deficient cystathionine beta-
synthase activity, is characterized by elevated homocysteine levels in
blood and early onset of severe osteoporosis of the spine and long bones.
The probability of homocysteinemia, in the absence of a genetic disease,
increases with age and after menopause and may result from several
factors: nutrient deficiencies (vitamin B6 and folic acid), malabsorption
(due to vitamin B12 deficiency, excess alcohol intake or non-steroidal
anti-inflammatory drug use), a high methionine diet (i.e., a high animal
protein diet) and/or unknown factors. Thus, it is our hypothesis that
elevated levels of homocysteine represent another risk factor for
osteoporosis.
We shall investigate the effects of elevated homocysteine on bone cell
growth, extracellular matrix synthesis, bone formation and bone resorption
by using an in vitro approach. Rat bone marrow cells, under the
appropriate culture conditions, can be induced to make bone or to produce
active osteoclasts. We shall add exogenous homocysteine or cause the
cells to produce elevated levels of homocysteine (by imposing nutrient
deficiencies) and assay effects on the parameters named above. Thus, we
shall be able to assess the effects of elevated homocysteine on the two
components of bone homeostasis, formation and resorption, at functional
levels.
If data supporting our hypothesis are obtained, we shall undertake a
cross-sectional study of plasma homocysteine levels in elderly people with
and without osteoporosis and, ultimately, for an intervention trial in
which dietary strategies are used to lower homocysteine levels.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
HOMOCYSTEINE MODIFIES BONE MATRIX AND MINERALIZATION
-
批准号:7229902
-
项目类别:
-
资助金额:$14.48万
-
财政年份:2006
-
负责人:CHARLES W PRINCE
-
依托单位:
HOMOCYSTEINE MODIFIES BONE MATRIX AND MINERALIZATION
-
批准号:7024679
-
项目类别:
-
资助金额:$17.34万
-
财政年份:2006
-
负责人:CHARLES W PRINCE
-
依托单位:
Homocysteine's role in the causation of presbyopia
-
批准号:6546989
-
项目类别:
-
资助金额:$7.25万
-
财政年份:2002
-
负责人:CHARLES W PRINCE
-
依托单位:
HOMOCYSTEINEMIA--A RISK FACTOR FOR OSTEOPOROSIS
-
批准号:3425967
-
项目类别:
-
资助金额:$4.95万
-
财政年份:1993
-
负责人:CHARLES W PRINCE
-
依托单位:
BIOCHEMICAL STUDIES OF MINERALIZED TISSUE PROTEOGLYCANS
-
批准号:3220236
-
项目类别:
-
资助金额:$10.93万
-
财政年份:1988
-
负责人:CHARLES W PRINCE
-
依托单位:
PROTEOGLYCANS AND OSTEOPONTIN IN BONE FORMATION
-
批准号:3072204
-
项目类别:
-
资助金额:$5.44万
-
财政年份:1988
-
负责人:CHARLES W PRINCE
-
依托单位:
PROTEOGLYCANS AND OSTEOPONTIN IN BONE FORMATION
-
批准号:3072205
-
项目类别:
-
资助金额:$5.28万
-
财政年份:1988
-
负责人:CHARLES W PRINCE
-
依托单位:
BIOCHEMICAL STUDIES OF MINERALIZED TISSUE PROTEOGLYCANS
-
批准号:2129389
-
项目类别:
-
资助金额:$16.75万
-
财政年份:1988
-
负责人:CHARLES W PRINCE
-
依托单位:
PROTEOGLYCANS AND OSTEOPONTIN IN BONE FORMATION
-
批准号:3072207
-
项目类别:
-
资助金额:$6.43万
-
财政年份:1988
-
负责人:CHARLES W PRINCE
-
依托单位:
PROTEOGLYCANS AND OSTEOPONTIN IN BONE FORMATION
-
批准号:3072206
-
项目类别:
-
资助金额:$6.35万
-
财政年份:1988
-
负责人:CHARLES W PRINCE
-
依托单位:
BIOCHEMICAL STUDIES OF MINERALIZED TISSUE PROTEOGLYCANS
-
批准号:2129387
-
项目类别:
-
资助金额:$18.87万
-
财政年份:1988
-
负责人:CHARLES W PRINCE
-
依托单位:
BIOCHEMICAL STUDIES OF MINERALIZED TISSUE PROTEOGLYCANS
-
批准号:3220235
-
项目类别:
-
资助金额:$9.89万
-
财政年份:1988
-
负责人:CHARLES W PRINCE
-
依托单位:
BIOCHEMICAL STUDIES OF MINERALIZED TISSUE PROTEOGLYCANS
-
批准号:2129388
-
项目类别:
-
资助金额:$16.03万
-
财政年份:1988
-
负责人:CHARLES W PRINCE
-
依托单位:
PROTEOGLYCANS AND OSTEOPONTIN IN BONE FORMATION
-
批准号:3072203
-
项目类别:
-
资助金额:$5.44万
-
财政年份:1988
-
负责人:CHARLES W PRINCE
-
依托单位:
BIOCHEMICAL STUDIES OF MINERALIZED TISSUE PROTEOGLYCANS
-
批准号:3220233
-
项目类别:
-
资助金额:$10.06万
-
财政年份:1984
-
负责人:CHARLES W PRINCE
-
依托单位:
BIOCHEMICAL STUDIES OF MINERALIZED TISSUE PROTEOGLYCANS
-
批准号:3220231
-
项目类别:
-
资助金额:$18.31万
-
财政年份:1984
-
负责人:CHARLES W PRINCE
-
依托单位:
BIOCHEMICAL STUDIES OF MINERALIZED TISSUE PROTEOGLYCANS
-
批准号:3447064
-
项目类别:
-
资助金额:$4.67万
-
财政年份:1984
-
负责人:CHARLES W PRINCE
-
依托单位:
BIOCHEMICAL STUDIES OF MINERALIZED TISSUE PROTEOGLYCANS
-
批准号:3220234
-
项目类别:
-
资助金额:$7.73万
-
财政年份:1984
-
负责人:CHARLES W PRINCE
-
依托单位:
BIOCHEMICAL STUDIES OF MINERALIZED TISSUE PROTEOGLYCANS
-
批准号:3447065
-
项目类别:
-
资助金额:$4.99万
-
财政年份:1984
-
负责人:CHARLES W PRINCE
-
依托单位:
BIOCHEMISTRY OF MINERALIZED TISSUE PROTEOGLYCANS; BONE; VIT; IN VIVO
-
批准号:3871682
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:CHARLES W PRINCE
-
依托单位: